Does DARATUMUMAB Cause Plasma cell myeloma? 2,980 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,980 reports of Plasma cell myeloma have been filed in association with DARATUMUMAB (DARZALEX). This represents 10.9% of all adverse event reports for DARATUMUMAB.
2,980
Reports of Plasma cell myeloma with DARATUMUMAB
10.9%
of all DARATUMUMAB reports
680
Deaths
439
Hospitalizations
How Dangerous Is Plasma cell myeloma From DARATUMUMAB?
Of the 2,980 reports, 680 (22.8%) resulted in death, 439 (14.7%) required hospitalization, and 95 (3.2%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 2,980 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
Neuropathy peripheral (955)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
RANITIDINE (856)
Which DARATUMUMAB Alternatives Have Lower Plasma cell myeloma Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE